4.1 Article

Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

Journal

THERAPEUTIC APHERESIS AND DIALYSIS
Volume 17, Issue 3, Pages 247-288

Publisher

WILEY
DOI: 10.1111/1744-9987.12058

Keywords

Chronic kidney disease-Mineral and Bone Disorders; Clinical practice guideline; Parathyroid hormone; Serum Calcium; Serum phosphorus; Vascular calcification

Funding

  1. Kyowa Hakko Kirin Co., Ltd. (a company producing and dealing prescription drugs)
  2. Chugai Pharmaceutical Co., Ltd. (a company producing, dealing, importing and exporting prescription drugs)
  3. Bayer Yakuhin, Ltd. (a company developing, importing, producing and dealing prescription drugs, medical devices and veterinary drugs)
  4. Daiichi Sankyo Co., Ltd. (a company researching, developing, producing and dealing prescription drugs)
  5. Tomita Pharmaceutical Co., Ltd. (a company producing and dealing prescription drugs, quasi drugs, cosmetics, industrial drugs, food additives and other related products)
  6. Abbott Japan Co., Ltd. (a company developing, producing and dealing prescription drugs, nutrients, medical devices, diagnostic drugs, and diagnostic devices)
  7. Japan Tobacco Inc. (a company producing and dealing tobacco, drugs, food, and beverage)
  8. Banyu Pharmaceutical Co., Ltd, (a company developing, importing, producing and dealing prescription drugs and medical devices)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available